Active, not recruitingPhase 2NCT04743661
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Studying Ependymoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Pediatric Brain Tumor Consortium
- Principal Investigator
- Matthias Karajannis, MD, MSMemorial Sloan Kettering Cancer Center
- Intervention
- Irinotecan(drug)
- Enrollment
- 62 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2022 – 2027
Study locations (3)
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Collaborators
National Cancer Institute (NCI) · Memorial Sloan Kettering Cancer Center · Y-mAbs Therapeutics
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04743661 on ClinicalTrials.govOther trials for Ependymoma
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1NCT04903080HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With EpendymomaChildren's Oncology Group
- RECRUITINGPHASE1NCT05106296Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerTheodore S. Johnson
- RECRUITINGNCT05151718Multiomic Approach to Radioresistance of Ependymomas in Children and AdolescentsInstitut Claudius Regaud
- ACTIVE NOT RECRUITINGPHASE1NCT04661384Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or MedulloblastomaCity of Hope Medical Center
- ACTIVE NOT RECRUITINGPHASE1NCT02774421Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent EpendymomaUniversity of Colorado, Denver
- RECRUITINGPHASE2, PHASE3NCT02265770An International Clinical Program for the Diagnosis and Treatment of Children With EpendymomaCentre Leon Berard
- ACTIVE NOT RECRUITINGPHASE2NCT02125786A Trial of Surgery and Fractionated Re-Irradiation for Recurrent EpendymomaSt. Jude Children's Research Hospital
- ACTIVE NOT RECRUITINGNCT00683319Observing Young Patients With Ependymoma Undergoing Standard Combination ChemotherapyChildren's Cancer and Leukaemia Group